{
    "nct_id": "NCT05780814",
    "official_title": "The Effects of Treating Insomnia on Behavioral Weight Loss Outcomes in Survivors of Breast Cancer",
    "inclusion_criteria": "* Female\n* 18 years of age or older\n* Histologically-confirmed Ductal Carcinoma In Situ (DCIS) or stage I-III invasive carcinoma of the breast\n* Eastern Cooperative Oncology Group (ECOG) performance status 0-2\n* Current BMI ≥ 25 kg/m2 and weight ≤ 400 lbs\n* Willing to lose 10% of body weight\n* Diagnosed within 10 years with histologically-confirmed DCIS or stage I-III invasive carcinoma of the breast\n* Completed local therapy (i.e. surgery and radiation therapy) and any planned preoperative or adjuvant chemotherapy/immunotherapy(/HER2) human epidermal growth factor receptor 2 therapy/targeted therapy at least 3months prior to enrollment (concomitant endocrine therapy allowed)\n* Completed all planned/elective surgeries >4 weeks before enrollment\n* Meet Diagnostic and Statistical Manual of Mental Disorders (DSM-5) criteria for Insomnia disorder\n* Self-reported initial sleep onset time and/or wake after sleep onset (WASO) time > 30 minutes, > 3 nights/week\n* Reports sleep problems present for ≥ 3 months\n* Insomnia Severity Index Score ≥ 9\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Serious/uncontrolled medical or psychiatric condition likely to hinder participation in BWL or CBT-l (bipolar disorder, psychotic disorder, seizure disorders, autoimmune disease, etc.)\n* Current use of medications that cause sleep disturbances or weight gain/loss. (-) Current sedative hypnotic use\n* Sleep disorder other than insomnia (mild sleep apnea or moderate to severe sleep apnea successfully treated via positive airway pressure (PAP) therapy is permitted\n* Currently enrolled or planning to enroll in a sleep treatment or weight loss program (agree not to enroll for the duration of the study) (-) Home sleep test Apnea/hypopnea Index (AHI) > 15\n* Participants also agree not to enroll in such a program for the duration of study participation (regardless of randomization).\n* History of unstable psychiatric disorder\n* Self-reported suicidal ideation or severe depressive symptoms as determined by clinical assessment, triggered by score of ≥ 20 on the Center for Epidemiologic Studies Depression (CES-D)\n* Lactating, pregnant or plan to become pregnant in next 14 months\n* Positive urine toxicology for recreational drugs of abuse; alcohol or substance use disorder as determined by Alcohol Use Disorders Identification Test, Adapted for Use in the United States (USAUDIT294) and/or Structured Clinical Interview (SCID)\n* Daily smoker/nicotine user\n* Anything that, in the opinion of the investigator, would place the subject at increased risk or preclude the patient's full compliance with or completion of the study",
    "miscellaneous_criteria": ""
}